SYS-CON MEDIA Authors: Eric Brown, Bob Gourley, Sandi Mappic, RealWire News Distribution, Kevin Benedict

News Feed Item

Seacoast Capital Announces Successful Investment in Walden Behavioral Care

DANVERS, MA -- (Marketwired) -- 07/17/14 -- Seacoast Capital ("Seacoast") announced today that it has successfully completed an investment in Walden Behavioral Care, LLC ("Walden"). Walden is New England's largest provider of behavioral health services for individuals with eating disorders. Walden was one of the first healthcare providers in the country to offer a full continuum of medical, behavioral, and nutritional care services for the treatment of eating disorders across inpatient, residential, partial hospitalization and intensive outpatient care settings. Walden's "whole health" approach integrates the best treatments currently offered in medicine, psychotherapy, nutrition, and healing therapies.

Walden is now capitalized to pursue an attractive growth strategy that will enable the company to further solidify its leadership position in the industry and enhance its service offerings of mental health treatment services throughout the region. Tom Gorman, Partner at Seacoast Capital, stated, "Dr. Koman and his team have built an extraordinary company dedicated to assisting both individuals and their families struggling with eating disorders and related mental health issues. We were attracted to the combination of Walden's core mission and the effectiveness of their programs. We are excited to partner with Walden and provide the necessary support to enable management to execute on its growth strategy."

About Walden Behavioral Care

Walden Behavioral Care, LLC, headquartered in Waltham, MA, was founded in 2003 by Dr. Stuart Koman. Walden is a behavioral health organization with multiple levels of care and includes a psychiatric hospital that treats eating disorders and psychiatric disorders. It is the only facility in New England that provides inpatient, residential, partial hospitalization and intensive outpatient care for patients with eating disorders. It is also the only facility in New England that provides dedicated inpatient care for mood disorders. By treating mental and physical conditions concurrently, Walden helps achieve lasting results for those who seek a meaningful recovery. Walden has satellite locations in Braintree, Worcester and Northampton, MA and South Windsor, CT. Walden created The Walden Center for Eating Disorder Education and Research as a 501(c)(3) nonprofit organization to educate the public about eating disorders and research treatment.

About Seacoast Capital

Seacoast Capital was founded in 1994 to make non-controlling subordinated debt and equity investments in privately-held lower middle market companies. Seacoast specializes in "sponsorless" transactions, preferring to invest directly with company owners or management teams, although it will selectively consider investments led by professional investor groups. Seacoast typically provides between $3 million and $12 million of debt and equity capital for acquisitions, growth, shareholder buyouts, management buyouts, and leveraged recapitalizations. While industry agnostic, Seacoast broadly invests in the specialty manufacturing, value-added distribution, and business services sectors. Seacoast generally targets investments in companies with $10 million to $150 million in revenue and $2 million or more of EBITDA. With offices in Boston and San Francisco, Seacoast has invested over $260 million in over 20 states since 1994. Seacoast is currently investing its third fund, Seacoast Capital Partners III, L.P.

For more information, or to submit an investment opportunity, please contact Tom Gorman at (978) 750-1311, or via e-mail at [email protected], or Alan Rich at (978) 750-1310, or via e-mail at [email protected].

Contact:
Alan Rich
Associate
Tel: (978) 750-1310
E-Mail: Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.